Certainly. Thank you very much for the question.
A number of factors have contributed to the need for the amendments to the Human Pathogens and Toxins Act, not the least of which has been significant investments in the biomanufacturing and life sciences strategy of the federal government, which has led to a significant increase in the number of facilities that are seeking to work with higher-risk pathogens and toxins.
The other piece that really contributed to it is an evolving threat landscape. There has been awareness of state actors and non-state actors who are interested in exploiting Canada's open science approach and are doing extremely good research in science, biotechnology and biomanufacturing. Awareness of this increased threat has led to some requirements to amend the legislation.